PYC Therapeutics moves into final stage of child blindness study
PYC Therapeutics (ASX:PYC) has been approved to escalate doses of its drug…
Pyc Therapeutics Limited (ASX:PYC)
About Pyc Therapeutics Limited
Key Information
PYC In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 16/12/2024 | Price Sensitive PS PYC Nominates Fourth Clinical Drug Candidate in PMS Program | 339.93KB | 7.1K |
| 28/11/2024 | Polycystic Kidney Disease Program Investor Presentation | 1.06MB | 10K |
| 27/11/2024 | Notification of cessation of securities - PYC | 12.87KB | 383 |
| 27/11/2024 | Notification regarding unquoted securities - PYC | 17.82KB | 318 |
| 27/11/2024 | Change of Director's Interest Notice | 223.88KB | 437 |
| 27/11/2024 | Price Sensitive PS PYC to Progress Kidney Drug Candidate Into Human Trials | 2.52MB | 4.2K |
| 22/11/2024 | Price Sensitive PS Presentation of RP11 Clinical Trial Data at APVRS 2024 | 1.31MB | 4.1K |
| 21/11/2024 | Completion of Share Consolidation | 176.7KB | 728 |